Literature DB >> 20206689

Differences in RNA processing underlie the tissue specific phenotype of ISCU myopathy.

Petter S Sanaker1, Marina Toompuu, Vanessa E Hogan, Langping He, Charalampos Tzoulis, Zofia M A Chrzanowska-Lightowlers, Robert W Taylor, Laurence A Bindoff.   

Abstract

Hereditary myopathy with lactic acidosis, or myopathy with exercise intolerance, Swedish type (OMIM #255125) is caused by mutations in the iron-sulfur cluster scaffold (ISCU) gene. The g.7044G>C ISCU mutation induces a splicing error in the pre-mRNA that strengthens a weak intronic splice site leading to inclusion of a new exon and subsequent loss of mRNA and protein. While ISCU is widely expressed, homozygosity for this particular intronic mutation gives rise to a pure myopathy. In order to investigate tissue specificity and disease mechanism, we studied muscle, myoblasts, fibroblasts and blood cells from the first non-Swedish case of this disease. Consistent with the recognised role of ISCU, we found abnormal activities of respiratory chain complexes containing iron-sulfur clusters in patient muscle. We confirmed that, in the presence of the g.7044G>C mutation, splicing produces both abnormally and normally spliced mRNA in all tissues. The ratio of these products varies dramatically between tissues, being most abnormal in mature skeletal muscle that also has the lowest relative starting levels of ISCU mRNA compared with other tissues. Myoblasts and fibroblasts have more of the normally spliced variant as well as higher starting levels of ISCU mRNA. Up-regulation of mtDNA copy number was found in skeletal muscle and myoblasts, but not fibroblasts, and is thought to represent a compensatory response. Tissue specificity in this disorder appears therefore to be dependent on the mRNA starting level, the amount of remaining normally spliced RNA, and the degree to which compensatory mechanisms can respond. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20206689     DOI: 10.1016/j.bbadis.2010.02.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

Review 1.  Differential diagnosis of lipoic acid synthesis defects.

Authors:  Frederic Tort; Xènia Ferrer-Cortes; Antonia Ribes
Journal:  J Inherit Metab Dis       Date:  2016-09-01       Impact factor: 4.982

2.  Use of antisense oligonucleotides to correct the splicing error in ISCU myopathy patient cell lines.

Authors:  Gregory P Holmes-Hampton; Daniel R Crooks; Ronald G Haller; Shuling Guo; Susan M Freier; Brett P Monia; Tracey A Rouault
Journal:  Hum Mol Genet       Date:  2016-12-01       Impact factor: 6.150

Review 3.  The spectrum of pyruvate oxidation defects in the diagnosis of mitochondrial disorders.

Authors:  Wolfgang Sperl; Leanne Fleuren; Peter Freisinger; Tobias B Haack; Antonia Ribes; René G Feichtinger; Richard J Rodenburg; Franz A Zimmermann; Johannes Koch; Isabel Rivera; Holger Prokisch; Jan A Smeitink; Johannes A Mayr
Journal:  J Inherit Metab Dis       Date:  2014-12-20       Impact factor: 4.982

4.  Tissue-specific splicing of ISCU results in a skeletal muscle phenotype in myopathy with lactic acidosis, while complete loss of ISCU results in early embryonic death in mice.

Authors:  Angelica Nordin; Elin Larsson; Lars-Eric Thornell; Monica Holmberg
Journal:  Hum Genet       Date:  2010-12-17       Impact factor: 4.132

5.  Tissue specificity of a human mitochondrial disease: differentiation-enhanced mis-splicing of the Fe-S scaffold gene ISCU renders patient cells more sensitive to oxidative stress in ISCU myopathy.

Authors:  Daniel R Crooks; Suh Young Jeong; Wing-Hang Tong; Manik C Ghosh; Hayden Olivierre; Ronald G Haller; Tracey A Rouault
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

6.  The presence of multiple cellular defects associated with a novel G50E iron-sulfur cluster scaffold protein (ISCU) mutation leads to development of mitochondrial myopathy.

Authors:  Prasenjit Prasad Saha; S K Praveen Kumar; Shubhi Srivastava; Devanjan Sinha; Gautam Pareek; Patrick D'Silva
Journal:  J Biol Chem       Date:  2014-02-26       Impact factor: 5.157

Review 7.  Iron-sulfur cluster biosynthesis and trafficking - impact on human disease conditions.

Authors:  C Wachnowsky; I Fidai; J A Cowan
Journal:  Metallomics       Date:  2018-01-24       Impact factor: 4.526

8.  Elevated FGF21 secretion, PGC-1α and ketogenic enzyme expression are hallmarks of iron-sulfur cluster depletion in human skeletal muscle.

Authors:  Daniel R Crooks; Thanemozhi G Natarajan; Suh Young Jeong; Chuming Chen; Sun Young Park; Hongzhan Huang; Manik C Ghosh; Wing-Hang Tong; Ronald G Haller; Cathy Wu; Tracey A Rouault
Journal:  Hum Mol Genet       Date:  2013-08-13       Impact factor: 6.150

9.  Friedreich's ataxia: the vicious circle hypothesis revisited.

Authors:  Aurélien Bayot; Renata Santos; Jean-Michel Camadro; Pierre Rustin
Journal:  BMC Med       Date:  2011-10-11       Impact factor: 8.775

10.  Insertion mutants in Drosophila melanogaster Hsc20 halt larval growth and lead to reduced iron-sulfur cluster enzyme activities and impaired iron homeostasis.

Authors:  Helge Uhrigshardt; Tracey A Rouault; Fanis Missirlis
Journal:  J Biol Inorg Chem       Date:  2013-02-27       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.